AAAAAA
Results:
1-15
|
Results: 15
Authors:
SHEMESH E
YANIV I
DRUCKER M
HADAD S
GOSHEN Y
STEIN J
ASH S
FISHER S
ZAIZOV R
Citation: E. Shemesh et al., HOME INTRAVENOUS ANTIBIOTIC-TREATMENT FOR FEBRILE EPISODES IN IMMUNE-COMPROMISED PEDIATRIC-PATIENTS, Medical and pediatric oncology, 30(2), 1998, pp. 95-100
Authors:
HADAD S
Citation: S. Hadad, GLASS LAMPS FROM THE BYZANTINE THROUGH MAMLUK PERIODS AT BET SHEAN, ISRAEL, Journal of glass studies, 40, 1998, pp. 63-76
Authors:
HADAD S
KHAMIS E
Citation: S. Hadad et E. Khamis, INSCRIBED POTTERY LAMPS FROM THE EARLY ISLAMIC PERIOD AT BETH-SHEAN, Israel exploration journal, 48(1-2), 1998, pp. 66-76
Authors:
HADAD S
BIALER M
Citation: S. Hadad et M. Bialer, PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF 2 NEW ISOMERS OF N-VALPROYL GLYCINAMIDE, Biopharmaceutics & drug disposition, 18(7), 1997, pp. 557-566
Authors:
HADAD S
Citation: S. Hadad, HEXAGONAL MOLD-BLOWN BOTTLES FROM THE BYZANTINE PERIOD AT BET SHEAN, ISRAEL, Journal of glass studies, 39, 1997, pp. 198-200
PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE
Authors:
BIALER M
HADAD S
KADRY B
ABDULHAI A
HAJYEHIA A
STERLING J
HERZIG Y
YAGEN B
Citation: M. Bialer et al., PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF TETRAMETHYLCYCLOPROPANE ANALOGS OF VALPROMIDE, Pharmaceutical research, 13(2), 1996, pp. 284-289
Authors:
HADAD S
EDOM R
MCKAY G
HAWES EM
MIDHA KK
Citation: S. Hadad et al., SIMULTANEOUS MEASUREMENT OF FLUPHENAZINE AND [H-2(4)]FLUPHENAZINE IN PLASMA USING SOLIDS PROBE TANDEM MASS-SPECTROMETRY, Journal of mass spectrometry., 30(6), 1995, pp. 849-856
Authors:
HADAD S
HUBBARD JW
MCKAY G
HAWES EM
SHRIKHANDE S
MIDHA KK
Citation: S. Hadad et al., EVIDENCE FOR THE LACK OF A HUMAN METABOLIC ISOTOPE EFFECT OF A DEUTERIUM ANALOG OF FLUPHENAZINE, Pharmaceutical research, 12(9), 1995, pp. 1388-1390
Authors:
HADAD S
BIALER M
Citation: S. Hadad et M. Bialer, PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF N-VALPROYL DERIVATIVES OF GABA AND GLYCINE, Pharmaceutical research, 12(6), 1995, pp. 905-910
Authors:
HADAD S
BIALER M
Citation: S. Hadad et M. Bialer, PHARMACOKINETIC ANALYSIS AND ANTIEPILEPTIC ACTIVITY OF NOVEL VALPROATE DERIVATIVES OF GABA AND GLYCINE, Epilepsia, 36, 1995, pp. 41-41
Authors:
ABUSALACH O
HADAD S
HAJYEHIA A
SUSSAN S
BIALER M
Citation: O. Abusalach et al., COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHLALOYL GLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY, Epilepsia, 36, 1995, pp. 163-163
Authors:
CASSOLA AC
HADAD S
SCHOR N
Citation: Ac. Cassola et al., A NOVEL LARGE-CONDUCTANCE CL CHANNEL IN RT MESANGIAL CELLS (MC) IN CULTURE, Journal of the American Society of Nephrology, 5(3), 1994, pp. 283-283
Authors:
BIALER M
HAJYEHIA A
BADIR K
HADAD S
Citation: M. Bialer et al., CAN WE DEVELOP IMPROVED DERIVATIVES OF VALPROIC ACID, Pharmacy world & science, 16(1), 1994, pp. 2-6
Authors:
ABUSALACH O
HADAD S
HAJYEHIA A
SUSSAN S
BIALER M
Citation: O. Abusalach et al., COMPARATIVE PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF PHTHALOYLGLYCINE DERIVATIVES WITH POTENTIAL ANTIEPILEPTIC ACTIVITY, Pharmaceutical research, 11(10), 1994, pp. 1429-1434
Authors:
BIALER M
HADAD S
GOLOMB G
BAREL S
SAMARA E
ABUSALACH O
BERKMAN N
DANENBERG HD
BENDAVID J
CARON D
KAPLAN R
TAMIR A
FRIEDMAN M
Citation: M. Bialer et al., PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT, Biopharmaceutics & drug disposition, 15(1), 1994, pp. 45-52
Risultati:
1-15
|